Solid Biosciences Inc (SLDB)
9.97
-0.13
(-1.29%)
USD |
NASDAQ |
May 06, 16:00
10.00
+0.04
(+0.35%)
After-Hours: 20:00
Solid Biosciences 1 Year Total Returns (Daily): 86.36% for May 6, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 06, 2024 | 86.36% |
May 03, 2024 | 90.57% |
May 02, 2024 | 95.23% |
May 01, 2024 | 80.34% |
April 30, 2024 | 81.76% |
April 29, 2024 | 80.12% |
April 26, 2024 | 91.06% |
April 25, 2024 | 87.28% |
April 24, 2024 | 82.33% |
April 23, 2024 | 87.45% |
April 22, 2024 | 86.01% |
April 19, 2024 | 80.12% |
April 18, 2024 | 87.07% |
April 17, 2024 | 98.21% |
April 16, 2024 | 93.69% |
April 15, 2024 | 97.24% |
April 12, 2024 | 98.09% |
April 11, 2024 | 120.7% |
April 10, 2024 | 127.5% |
April 09, 2024 | 141.8% |
April 08, 2024 | 149.2% |
April 05, 2024 | 160.9% |
April 04, 2024 | 160.6% |
April 03, 2024 | 162.5% |
April 02, 2024 | 155.3% |
Date | Value |
---|---|
April 01, 2024 | 162.4% |
March 28, 2024 | 235.5% |
March 27, 2024 | 267.3% |
March 26, 2024 | 268.8% |
March 25, 2024 | 269.0% |
March 22, 2024 | 263.8% |
March 21, 2024 | 246.7% |
March 20, 2024 | 260.6% |
March 19, 2024 | 258.9% |
March 18, 2024 | 225.1% |
March 15, 2024 | 172.5% |
March 14, 2024 | 145.6% |
March 13, 2024 | 130.8% |
March 12, 2024 | 132.2% |
March 11, 2024 | 132.4% |
March 08, 2024 | 110.6% |
March 07, 2024 | 86.42% |
March 06, 2024 | 81.50% |
March 05, 2024 | 79.25% |
March 04, 2024 | 82.83% |
March 01, 2024 | 77.64% |
February 29, 2024 | 67.08% |
February 28, 2024 | 68.15% |
February 27, 2024 | 76.53% |
February 26, 2024 | 58.33% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.60%
Minimum
Mar 02 2022
269.0%
Maximum
Mar 25 2024
-34.79%
Average
-65.78%
Median
Apr 19 2023
1 Year Total Returns (Daily) Benchmarks
Sarepta Therapeutics Inc | 3.08% |
PTC Therapeutics Inc | -40.92% |
Capricor Therapeutics Inc | 41.07% |
Perspective Therapeutics Inc | 177.7% |
Electromed Inc | 57.33% |